3.8 Review

Resveratrol modulation of signal transduction in apoptosis and cell survival: A mini-review

Journal

CANCER DETECTION AND PREVENTION
Volume 30, Issue 3, Pages 217-223

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.cdp.2006.03.007

Keywords

resveratrol; signaling network; MAPK signaling; signal transduction; mitochondrial pathway; NF-kappaB; tyrosine kinase pathway; survivin; chemoprevention; prevention; apoptosis; survival; cancer

Categories

Ask authors/readers for more resources

Background: There is mounting evidence in the literature that resveratrol is a promising natural compound for prevention and treatment of a variety of human cancers. This overview summarizes recent studies of the major apoptosis and survival pathways regulated by resveratrol. Biological mechanisms: Apoptosis or programmed cell death is a key regulator of tissue homeostasis during normal development and also in adult organism under various conditions including adaptive responses to cellular stress For example, tissue homeostasis is maintained by tight control of signaling events regulating cell death and survival. Thus, uncontrolled proliferation or failure to undergo cell death is involved in pathogenesis and progression of many human diseases, for example in tumorigenesis or in cardiovascular disorders. Moreover, current cancer therapies primarily act by triggering apoptosis programs in cancer cells. Therapeutic applications: Natural products such as resveratrol have gained considerable attention as cancer chemopreventive or cardioprotective agents and also because of their antitumor properties. Among its wide range of biological activities, resveratrol has been reported to interfere with many intracellular signaling pathways, which regulate cell survival or apoptosis. Discussion: Further insights into the signaling network and interaction points modulated by resveratrol may provide the basis for novel drug discovery programs to exploit resveratrol for the prevention and treatment of human diseases. (c) 2006 International Society for Preventive Oncology. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available